Statins and the Struggle for Transparency

This chapter explores the fallout from a contentious publication on statins, examining the backlash from medical authorities and the media. It addresses the ethical dilemmas posed by the pharmaceutical industry, including conflicts of interest and the manipulation of medical guidelines. Highlighting the need for lifestyle changes over medication, the chapter calls for greater accountability and skepticism within the medical field.